Guibao, Baby Boy .
HRN: 24-67-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFOTAXIME 500MG (VIAL)
03/13/2024
03/19/2024
IVT
160mg
Q12
Psnb, Thickly Msaf
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes